Fulgent Genetics
biotechnology company
FLGT Nasdaq
ISIN US3596641098 SEC CIK 1674930 LEI 549300CL6P01M68QJ404
Follow Fulgent Genetics
Weekly email: filings, results
Revenue, last quarter
$90.4M
+7.5% vs same quarter last year
Net income
−$13.2M
−99% vs same quarter last year
EPS, diluted
-
Operating cash flow
$109.2M
+883.5% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $322.7M | −$60.5M |
| FY24 | $283.5M | −$42.7M |
| FY23 | $289.2M | −$167.8M |
| FY22 | $619M | $143.4M |
| FY21 | $992.6M | $507.4M |
| FY20 | $421.7M | $214.3M |
| FY19 | $32.5M | −$411K |
| FY18 | $21.4M | −$5.6M |
| FY17 | $18.7M | −$2.5M |
| FY16 | $18.3M | −$5.3M |
| FY15 | $9.6M | −$8.3M |
| FY14 | $1.3M | −$4.3M |
| FY13 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 40.6% | −28.2% | −18.8% |
| FY24 | 37.8% | −26.1% | −15.1% |
| FY23 | 36.1% | −67.6% | −58% |
| FY22 | 59.3% | 28.8% | 23.2% |
| FY21 | 78.3% | 68.1% | 51.1% |
| FY20 | 78.7% | 68.8% | 50.8% |
| FY19 | 56.6% | −1.3% | −1.3% |
| FY18 | 49.9% | −23.7% | −26.3% |
| FY17 | 54.3% | −18.6% | −13.4% |
| FY16 | 63.2% | 5% | −29.3% |
| FY15 | 47.1% | −52.3% | −86.8% |
| FY14 | 26.8% | −77.5% | −335.1% |
| FY13 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$124.2M |
| FY24 | −$19.3M |
| FY23 | $4.8M |
| FY22 | $234.7M |
| FY21 | $514.8M |
| FY20 | $105.5M |
| FY19 | $4.3M |
| FY18 | −$3M |
| FY17 | −$1.6M |
| FY16 | $617K |
| FY15 | −$3.1M |
| FY14 | −$5.1M |
| FY13 | - |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | $10.9M |
| FY24 | $225K |
| FY23 | $25.1M |
| FY22 | $74.3M |
| FY21 | - |
| FY20 | $62K |
| FY19 | $21K |
| FY18 | - |
| FY17 | - |
| FY16 | - |
| FY15 | - |
| FY14 | - |
| FY13 | - |
- Fulgent Genetics
- Healthcare median
Show the numbers
| Year | Fulgent Genetics | Healthcare median |
|---|---|---|
| FY25 | −18.8% | −30.6% |
| FY24 | −15.1% | −47% |
| FY23 | −58% | −58% |
| FY22 | 23.2% | −80.4% |
| FY21 | 51.1% | −71.8% |
| FY20 | 50.8% | −62.2% |
| FY19 | −1.3% | −46.2% |
| FY18 | −26.3% | −49.6% |
| FY17 | −13.4% | −45.9% |
| FY16 | −29.3% | −36% |
| FY15 | −86.8% | −37.8% |
| FY14 | −335.1% | −35.5% |
| FY13 | - | −37.1% |